ETH-40

N/A

Report date: 2024/11/06 15:20:39

Base Information

Drug NameETH-40
Drug Alias NameETH-40ETH40
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBone morphogenetic protein 2 stimulants
TargetsBone morphogenetic protein 2
Therapy Area/IndicationsBone Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEthris GmbH
China Registration ClassN/A

Develop Information

Active CompaniesEthris GmbH
Inactive CompaniesN/A
Active IndicationsBone Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A